Results

Total Results: 1,099 records

Showing results for "evaluate".

261. Archived: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
     July 07, 2015 - speech and language development may be associated with autism spectrum disorder, this review did not evaluate … The USPSTF also noted that this recommendation does not evaluate screening for autism spectrum disorder

262. Evidence Summary: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/sexually-transmitted-infections-behavioral-counseling
     August 18, 2020 - Based on a priori plans to evaluate differences in intervention effects by age, 2 sets of data tables … A randomized trial to evaluate the efficacy of a web-based HIV behavioral intervention for high-risk … framework to visually display the key questions that the review will address to allow the USPSTF to evaluate … unintended pregnancy risk or mental health One study reported car crashes associated with text messages to evaluate

263. Screening for Osteoporosis to Prevent Fractures: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ffNDS7ekxovstoCxxtLJVt
     February 13, 2018 - the USPSTF used BMD measured by peripheral DXA to define treatment threshold QUS Uses ultrasound to evaluate … More stud- ies are also needed that evaluate the direct effect of screening for osteoporosis (either … Fewer stud- ies are available that evaluate the performance of these tools spe- cifically in younger

264. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
     August 22, 2023 - trials; n = 6928; RR, 0.28 [95% CI, 0.20-0.41]). 10 , 22 , 43 , 52 , 63 These trials were designed to evaluate … Third, the findings were based on analyses of study level data, limiting the ability to evaluate subgroup … framework to visually display the key questions that the review will address to allow the USPSTF to evaluate … to assess consistency; precise No reporting bias detected Good Duration may be insufficient to evaluate

265. Final Evidence Summary: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/screening-depression-suicide-risk-children-adolescents
     October 11, 2022 - analytic framework to visually display the key questions that the review addressed to allow the USPSTF to evaluate

266. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
     July 01, 2004 - Screening for Syphilis: A Brief Update Background Syphilis is a systemic infectious disease caused by sexual or congenital transmission of the bacterium Treponema pallidum (T. pallidum). Syphilis causes a variety of symptoms corresponding to stages of infection (primary, secondary, tertiary) and no symptoms during l…

267. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
     June 20, 2019 - Using CD4 counts to evaluate the stages and epidemiology of HIV infection in South Carolina public clinic

268. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
     March 15, 2005 - A fair-quality, randomized, double blind, placebo controlled trial was conducted to evaluate the use … The study was not designed to evaluate the safety of suppressive acyclovir on the fetus. … A poor-quality, randomized, double blind, placebo controlled trial was conducted to evaluate the efficacy

269. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
     March 01, 2005 - : Brief Update A fair-quality, randomized, double blind, placebo controlled trial was conducted to evaluate … randomized controlled trial. 17 Screening for Genital Herpes Simplex: Brief Update designed to evaluate … A poor-quality, randomized, double blind, placebo controlled trial was conducted to evaluate the efficacy

270. Archived: Final Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary50/impaired-visual-acuity-in-older-adults-screening-2009
     July 15, 2009 - To evaluate indirect evidence on screening, investigators included studies of diagnostic test accuracy … screening to be associated with an increased risk for falls in frail elderly patients. 20 No studies that evaluate … sham injection (RR, 0.77 [CI, 0.65-0.92]) Fair Regillo et al, 2008 65 To evaluate … injection 33/63 (52.4%) Good Rosenfeld et al, 2006 66 ; Boyer et al, 2007 91 To evaluate

271. Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
     March 09, 2021 - 0.1% of patients screened, and death in the 60 days following the most invasive procedure performed to evaluate … Research is needed to evaluate whether, as lung cancer screening is implemented in more diverse community

272. Archived: Final Evidence Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review49/hepatitis-c-screening-2013
     November 15, 2012 - Clinical studies that prospectively evaluate the accuracy, yield, and outcomes of alternative HCV screening

273. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - framework to visually display the key questions that the review will address to allow the USPSTF to evaluate

274. Screening for Dyslipidemia in Younger Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SaASReVeD_fpHZQbeBZD5s
     October 01, 2016 - American Heart Association guideline on assessing cardiovascular risk considers it “reasonable” to evaluate … Because very large, long-term trials would be required to evaluate screening of younger adults in the

275. Archived: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-december-2013
     December 31, 2013 - cancer screening with LDCT is implemented more widely in diverse community settings, it is important to evaluate

276. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
     July 20, 2021 - difference was not statistically significant.19 Addi- tional included trials were primarily designed to evaluate … research should also in- clude trials or well-designed cohort studies in average-risk popula- tions to evaluate … Sec- ond, it included only trials or prospective cohort studies designed to evaluate the association … When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we

277. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
     November 01, 2021 - studies, trials, or well-designed cohort studies with av- erage-risk populations are still needed to evaluate … When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do

278. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
     March 09, 2021 - framework to visually display the key questions that the review will address to allow the USPSTF to evaluate

279. Procedure Manual Appendix VI. Criteria for Assessing Internal Validity of Individual Studies | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vi-criteria-assessing-internal-validity-individual-studies
     July 01, 2017 - Procedure Manual Appendix VI. Criteria for Assessing Internal Validity of Individual Studies Share to Facebook Share to X Share to WhatsApp Share to Email Print The USPSTF Methods Workgroup developed a set of criteria by which the internal va…

280. Archived: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Research is needed to evaluate the optimal frequency of cardiovascular risk assessment, including serum … Currently, there is no trial evidence to evaluate the net benefit of initiating statin therapy in this